Davis Polk advised Notre Dame Intermédica Participações S.A. in connection with the initial public offering by Notre Dame Intermédica and by Bain Capital, the controlling shareholder of Notre Dame Intermédica, of 146,484,361 common shares of Notre Dame Intermédica for an aggregate amount of R$2.4 billion (approximately $691 million). The common shares trade on the São Paulo Stock Exchange. Common shares sold in the international offering were placed under Rule 144A and Regulation S.

Headquartered in São Paulo, Brazil, Notre Dame Intermédica is a healthcare services company in Brazil, focused on selling employer-sponsored health and dental plans and delivering high-quality and cost-effective services, primarily to the Brazilian middle class.

The Davis Polk corporate team included Manuel Garciadiaz, Drew Glover and Lourenco Lopes-Sabino. Alon Gurfinkel and Omer Harel provided tax advice. Zixuan (Jennifer) Wang provided Investment Act advice. Members of the Davis Polk team are based in the São Paulo, London, Northern California and New York offices. 

Copy link to share post